Schedule 13D ownership disclosure

LAKEFRONT BIOTHERAPEUTICS NV

Security class unavailable · CUSIP: 36315X101

Event date: 2019-07-14

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
6,760,701
Percent of class
12.3000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-19-041473
Form type
SC 13D
Filer
Lakefront Biotherapeutics NV
CIK
CIK 1421876
Filed
Jul 23, 2019
Reporting period
Jul 14, 2019
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub